Related Experiment Video
Updated: Jun 13, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Ethinylestradiol/dienogest in oral contraception
1Service of Gynaecology, Hospital General Requena, Valencia, Spain. Perez_eze@gva.es
Drugs
|April 17, 2010
Summary
Ethinylestradiol/dienogest is a highly effective oral contraceptive with significant benefits for cycle control and skin conditions. This widely used option demonstrates good tolerability and does not impair long-term fertility.
Area of Science:
- Pharmacology
- Gynecology
- Endocrinology
Background:
- Ethinylestradiol/dienogest is a widely prescribed low-dose combined oral contraceptive.
- Dienogest, a novel progestin, possesses unique pharmacokinetic and antiandrogenic properties.
Purpose of the Study:
- To evaluate the efficacy, safety, and tolerability of ethinylestradiol/dienogest.
- To assess its impact on hormonal levels, metabolic parameters, and dermatological conditions.
Main Methods:
- Clinical studies were conducted to assess contraceptive efficacy and ovulation inhibition.
- Pharmacokinetic and pharmacological profiles were analyzed.
- Effects on hormonal balance, metabolism, hemostasis, and dermatological outcomes were investigated.
Main Results:
- High contraceptive efficacy comparable to other combined oral contraceptives.
- Effective cycle control, reduced menstrual bleeding, and improved dysmenorrhea.
- Reduced serum androgen levels, beneficial effects on acne vulgaris, hair, and skin greasiness.
- Minor metabolic and hemostatic influences; well-tolerated with rare adverse effects.
Conclusions:
- Ethinylestradiol/dienogest is a reliable and well-tolerated oral contraceptive with significant non-contraceptive benefits.
- It offers effective cycle regulation and improvements in androgen-dependent conditions.
- No long-term impairment of fertility observed after discontinuation.
Related Concept Videos
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:22Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
01:29Diels–Alder Reaction Forming Bridged Bicyclic Products: Stereochemistry
Diels–Alder reactions between cyclic dienes locked in an s-cis configuration and dienophiles yield bridged bicyclic products.
01:06Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
01:18Drug Delivery: Enteral Route
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
Drugs in...
Drugs in...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...